(Q33958533)

30 July 2017

title

Deferasirox and deferiprone remove cardiac iron in the iron-overloaded gerbil (English)

1 reference

30 July 2017

John C Wood

1

1 reference

30 July 2017

Maya Otto-Duessel

2

1 reference

30 July 2017

Ignacio Gonzalez

3

1 reference

30 July 2017

Michelle I Aguilar

4

1 reference

30 July 2017

Hiro Shimada

5

1 reference

30 July 2017

Hanspeter Nick

6

1 reference

30 July 2017

Marvin Nelson

7

1 reference

30 July 2017

Rex Moats

8

1 reference

30 July 2017

publication date

1 November 2006

1 reference

30 July 2017

published in

Translational Research

1 reference

30 July 2017

volume

148

1 reference

30 July 2017

issue

5

1 reference

30 July 2017

page(s)

272-280

1 reference

Cardiac iron determines cardiac T2*, T2, and T1 in the gerbil model of iron cardiomyopathy.

30 July 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2896322

LPI-labile plasma iron in iron overload

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2896322

Effectiveness and safety of ICL670 in iron-loaded patients with thalassaemia: a randomised, double-blind, placebo-controlled, dose-escalation trial

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2896322

Comparative effects of deferiprone and deferoxamine on survival and cardiac disease in patients with thalassemia major: a retrospective analysis

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2896322

The cardiac ryanodine receptor (calcium release channel): emerging role in heart failure and arrhythmia pathogenesis.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2896322

ICL670A: a new synthetic oral chelator: evaluation in hypertransfused rats with selective radioiron probes of hepatocellular and reticuloendothelial iron stores and in iron-loaded rat heart cells in culture

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2896322

Hepatic iron concentration and total body iron stores in thalassemia major.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2896322

Meta-analytic review of the clinical effectiveness of oral deferiprone (L1).

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2896322

Iron-chelating therapy and the treatment of thalassemia.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2896322

Results of long-term iron-chelating therapy

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2896322

Efficacy of deferoxamine in preventing complications of iron overload in patients with thalassemia major

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2896322

Iron(II) is a modulator of ryanodine-sensitive calcium channels of cardiac muscle sarcoplasmic reticulum

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2896322

Nitroxyl triggers Ca2+ release from skeletal and cardiac sarcoplasmic reticulum by oxidizing ryanodine receptors

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2896322

Myocardial iron clearance during reversal of siderotic cardiomyopathy with intravenous desferrioxamine: a prospective study using T2* cardiovascular magnetic resonance

29 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2896322

Survival and complications in patients with thalassemia major treated with transfusion and deferoxamine

29 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2896322

Cardiac status in well-treated patients with thalassemia major

29 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2896322

Deferoxamine prevents cardiac hypertrophy and failure in the gerbil model of iron-induced cardiomyopathy

29 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2896322

The oral iron chelator ICL670A (deferasirox) does not protect myocytes against doxorubicin

29 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2896322

Optical mapping reveals conduction slowing and impulse block in iron-overload cardiomyopathy.

29 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2896322

Does the gerbil model mimic human iron overload?

29 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2896322

Safety, tolerability, and pharmacokinetics of ICL670, a new orally active iron-chelating agent in patients with transfusion-dependent iron overload due to beta-thalassemia

29 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2896322

Deferoxamine promotes survival and prevents electrocardiographic abnormalities in the gerbil model of iron-overload cardiomyopathy

29 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2896322

Redox regulation of calcium release in skeletal and cardiac muscle.

29 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2896322

Comparison of effects of oral deferiprone and subcutaneous desferrioxamine on myocardial iron concentrations and ventricular function in beta-thalassaemia

29 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2896322

The iron-loaded gerbil model revisited: effects of deferoxamine and deferiprone treatment

29 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2896322

Safety of oral iron chelator L1.

29 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2896322

Characterization of Fe2+ and Fe3+ transport by iron-loaded cardiac myocytes

29 October 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2006.05.005

Potentiation of iron accumulation in cardiac myocytes during the treatment of iron overload in gerbils with the hydroxypyridinone iron chelator CP94

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2006.05.005

Decreased sodium and increased transient outward potassium currents in iron-loaded cardiac myocytes. Implications for the arrhythmogenesis of human siderotic heart disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2006.05.005

Bimodal cardiac dysfunction in an animal model of iron overload

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2006.05.005

The heart in sickle cell anemia. The Cooperative Study of Sickle Cell Disease (CSSCD)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2006.05.005

Toxicity of oral iron chelator L1

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2006.05.005

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2006.05.005

Cardiac iron deposition in idiopathic hemochromatosis: histologic and analytic assessment of 14 hearts from autopsy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2006.05.005

Myocardial iron loading in transfusion-dependent thalassemia and sickle cell disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2006.05.005

A unique rodent model for both the cardiotoxic and hepatotoxic effects of prolonged iron overload

7 January 2021

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/17145573

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Iron chelation therapy

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/17145573

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1016/J.TRSL.2006.05.005

1 reference

30 July 2017

1 reference

30 July 2017

1 reference